Boston, MACIK 13353254 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
145 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Invesco Db Commdy Indx Trck | 1.06M | $23.64M | 6.1% | −378.9K | Reduced |
| 2 | Structure Therapeutics Inc | 193.0K | $13.42M | 3.5% | −43.2K | Reduced |
| 3 | Cogent Biosciences Inc | 336.7K | $11.96M | 3.1% | −125.7K | Reduced |
| 4 |
| 372.5K |
| $11.59M |
| 3.0% |
| −96.9K |
| Reduced |
| 5 | Abivax SA | 72.2K | $9.73M | 2.5% | −112.3K | Reduced |
| 6 | Revolution Medicines Inc | 120.2K | $9.58M | 2.5% | −55.2K | Reduced |
| 7 | Praxis Precision Medicines I | 25.8K | $7.62M | 2.0% | −69.2K | Reduced |
| 8 | Nuvalent Inc | 73.3K | $7.37M | 1.9% | −20.0K | Reduced |
| 9 | Cytokinetics Inc | 114.6K | $7.28M | 1.9% | −18.4K | Reduced |
| 10 | Terns Pharmaceuticals Inc | 175.5K | $7.09M | 1.8% | +175.5K | New |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio